Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for macular edema from central retinal vein occlusion

被引：374

作者：

Rosenfeld, PJ ^{[1
]}

Fung, AE ^{[1
]}

Puliafito, CA ^{[1
]}

机构：

[1] Univ Miami, Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA

来源：

OPHTHALMIC SURGERY LASERS & IMAGING | 2005年 / 36卷 / 04期

关键词：

D O I：

10.3928/1542-8877-20050701-15

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

To determine whether bevacizumab could improve visual acuity and optical coherence tomography outcomes in a patient with macular edema from central retinal vein occlusion, an intravitreal injection of bevacizumab (1.0 mg) was given. Prior intravitreal injections of triamcinolone acetonide resulted in vision improvement but worsening cataract and borderline glaucoma. Within 1 week of the bevacizumab injection, visual acuity improved from 20/200 to 20/50 and optical coherence tomography revealed resolution of the cystic maculopathy. The improvements were maintained for at least 4 weeks. Intravitreal injections of bevacizumab may provide another treatment option for patients with macular edema from vein occlusions.

引用

页码：336 / 339

页数：4

共 13 条

[1] New therapy for central retinal vein occlusion - Are intravitreal steroids a possible answer? [J].

Blumenkranz, MS .

ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (02) :259-261

[2] Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease - It's tintefor clinical trials [J].

Flynn, HW ;

Scott, IU .

ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (02) :258-259

[3] Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion [J].

Greenberg, PB ;

Martidis, A ;

Rogers, AH ;

Duker, JS ;

Reichel, E .

BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (02) :247-248

[4] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

[5] Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion [J].

Ip, MS ;

Gottlieb, ML ;

Kahana, A ;

Scott, IU ;

Altaweel, MM ;

Blodi, BA ;

Gangnon, RE ;

Puliafito, CA .

ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (08) :1131-1136

[6]

Ip MS, 2002, ARCH OPHTHALMOL-CHIC, V120, P1217

[7] Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion [J].

Jonas, JB ;

Kreissig, I ;

Degenring, RF .

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2002, 240 (09) :782-783

[8] Intravitreal triamcinolone acetonide for the treatment of central retinal vein occlusion in young patients [J].

Karacorlu, M ;

Ozdemir, H ;

Karacorlu, S .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2004, 24 (02) :324-327

[9] Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion [J].

Kaushik, S ;

Gupta, V ;

Gupta, A ;

Dogra, MR ;

Singh, R .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 137 (04) :758-760

[10] Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion [J].

Krepler, K ;

Ergun, E ;

Sacu, S ;

Richter-Müksch, S ;

Wagner, J ;

Stur, M ;

Wedrich, A .

ACTA OPHTHALMOLOGICA SCANDINAVICA, 2005, 83 (01) :71-75

← 1 2 →